What is PetMed Express, Inc. (PETS) stock price today?

PetMed Express, Inc. (PETS) is currently trading at $1.29, up 0.39% today.

What is PETS P/E ratio?

PetMed Express, Inc.'s P/E ratio is -0.99. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PETS return on equity (ROE)?

PetMed Express, Inc.'s return on equity (ROE) is -108.76%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is PetMed Express, Inc.'s market cap?

PetMed Express, Inc. has a market capitalization of $27.46M.

NASDAQ · Medical - Pharmaceuticals

PetMed Express, Inc. (PETS) Stock

$1.29 +0.39% NASDAQ: PETS Healthcare

Valuation

Metric	Value
Price	$1.29
Market Cap	$27.46M
P/E Ratio	-0.99
P/B Ratio	1.28
P/S Ratio	0.17
EPS (TTM)	$-0.30
52-Week High	$4.10
52-Week Low	$1.27
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-108.76%
ROA	-45.92%
ROCE	-132.85%
Gross Margin	-0.88%
Operating Margin	-0.88%
Net Margin	-17.34%
Debt/Equity	0.02
Current Ratio	1.25

Annual Financials (USD)

Metric	2022	2023	2024	2025	2026
Revenue	$273.0M	$257.0M	$274.0M	$227.0M	$179.0M
Operating Profit	$26.0M	$7.0M	$-7.0M	$-2.0M	$-31.0M
Net Profit	$21.0M	$5.0M	$-7.0M	$-6.0M	$-57.0M
EPS	$1.04	$0.25	$-0.37	$-0.30	$-2.74
Op Margin	9.4%	2.5%	-2.5%	-0.7%	-17.6%

Balance Sheet (USD)

Metric	2022	2023	2024	2025	2026
Total Assets	$176.0M	$170.0M	$170.0M	$149.0M	$81.0M
Total Liabilities	$34.0M	$60.0M	$73.0M	$64.0M	$52.0M
Cash	$111.0M	$104.0M	$55.0M	$55.0M	$21.0M
Borrowings	$0	$1.0M	$1.0M	$1.0M	$1.0M

Latest News

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform GlobeNewswire · Jul 14, 2026 Sector Update: Healthcare Stocks Decline Tuesday Afternoon MT Newswires · Jun 30, 2026 PetMed Express Receives Unsolicited Acquisition Proposal From SilverCape Investments MT Newswires · Jun 30, 2026 PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited GlobeNewswire · Jun 30, 2026 SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash GlobeNewswire · Jun 29, 2026

Cash Flow (USD)

Metric	2022	2023	2024	2025	2026
Operating Cash Flow	$18.0M	$28.0M	$4.0M	$5.0M	$-28.0M
Investing Cash Flow	$-4.0M	$-16.0M	$-45.0M	$-10.0M	$-9.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-8.0M	$-7.0M	$-49.0M	$-1.0M	$-33.0M
Free Cash Flow	$17.0M	$23.0M	$0	$0	$-33.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.23
EV / EBITDA	-0.75
FCF Yield	-95.56%
Quick Ratio	0.47
Interest Coverage	-69.47
Return 1Y	-35.66%
Return 3Y	-84.99%
Return 5Y	-92.05%

Ownership

Insiders Held15.57%

Institutions Held44.54%

Institutions Float Held52.75%

Institutional Holder	Shares	Report Date
Renaissance Technologies, LLC	1,186,369	2026-03-31
Vanguard Capital Management LLC	831,431	2026-03-31
Federated Hermes, Inc.	666,805	2026-03-31
Blackrock Inc.	551,677	2026-03-31
Hotchkis & Wiley Capital Management, LLC	514,543	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BDSXBiodesix, Inc.	$26.02	+1.52%	-8.74	$211.81M	0.00%
CTSOCytosorbents Corporation	$3.79	+1.61%	-0.65	$11.91M	0.00%
FBIOFortress Biotech, Inc.	$2.13	+2.15%	0.64	$70.92M	0.00%
GNTAGenenta Science S.p.A.	$1.50	-5.66%	-3.98	$28.72M	0.00%
ICCMIceCure Medical Ltd.	$1.10	-2.65%	-0.23	$2.48M	0.00%

About PetMed Express, Inc.

PetMed Express, Inc. is led by CEO Leslie C. G. Campbell, employs 287 people, headquartered in US, publicly traded since 1999.

PetMed Express, Inc. (PETS) stock trades at $1.29 with a market capitalization of $27.46M. The stock is valued at a price-to-earnings (P/E) ratio of -0.99, price-to-book of 1.28, price-to-sales of 0.17. Over the past 52 weeks the stock has ranged between $1.27 and $4.10, and currently trades 68.5% below its 52-week high.

On profitability, PetMed Express, Inc. generates a return on equity (ROE) of -108.76%, return on capital employed of -132.85%, an operating margin of -0.88%, a net profit margin of -17.34%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides